This site is intended for managed care professionals in the U.S.

This site is intended for managed care professionals in the U.S.

Professionals in Canada should visit

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Non-CE Education Resources

Generic filters

Continuous Glucose Monitoring: Using New Evidence and Digital Innovations to Optimize Diabetes Care Management

Source: AMCP Science and Innovation Theater Webinar – February 16, 2022

Key Takeaway:

The Dexcom CGM system is unique with the ability to connect with multiple digital health solutions. Combining CGM with digital health apps allows users to quickly see all their data in one place. Access to real-time data can empower people with diabetes and foster patient engagement with in-the-moment diabetes feedback and the opportunity for coaching.

The recently updated American Diabetes Association (ADA) Standards of Care (SOC) 20221 revised the technology recommendations focusing on use of continuous glucose monitoring (CGM). In addition, the ADA added digital health to the recommendations noting the opportunity for digital coaching as a tool for education. Join this webinar for a deep dive into the updated CGM technology SOC and learn about the current evidence that influenced recent changes. Diabetes technology is evolving rapidly, stay up to date with CGM to enhance your knowledge.

1. American Diabetes Association. Diabetes Care. 2022;45(Suppl1):S97-S112

The Pharmacist’s Evolving Role in Diabetes Management: The Power of Real-Time Continuous Glucose Monitoring

Watch the APhA 2021 Annual Meeting and Exposition Presentation Theatre on the power of real-time continuous glucose monitoring, featuring:

Dr. Diana Isaacs
Endocrine Clinical Pharmacist & Remote Monitoring Program Coordinator
Cleveland Clinic

Dr. Jessica Haskins
Community Walgreens Site Manager
Austin, TX

Personal CGM Implementation Playbook

Source: Association of Diabetes Care & Education Specialists and American Pharmacists Association

Key Takeaway: Developed by the Association for Diabetes Care and Education Specialists in partnership with APhA, this newly created Personal Continuous Glucose Monitoring (CGM) Implementation Playbook will help you implement a personal CGM program within your pharmacy practice.

This guide brings together fragmented information available from multiple sources to provide an inclusive and unbiased approach to implementation of Personal CGM into your practice, whatever its size. It includes a step-by-step approach to implementation, additional resources, and the latest research.

Download this free guide and start the process of incorporating this potentially game-changing tool for your patients living with diabetes.

Professional CGM Implementation Playbook

Source: Association of Diabetes Care & Education Specialists and American Association of Nurse Practitioners 

Key Takeaway: This toolkit provided by ADCES and AANP will help you implement a professional CGM program within your health system. Implementing a program within a healthcare setting offers many advantages, including: promotion of self-motivated, data-driven behavior change and improved clinical outcomes through alignment of medication with behavior change, resulting in lowered long-term healthcare costs for people with type 1 and type 2 diabetes.

Podcast: Clinical Outcomes and Best Practices for CGM Use in Seniors

Key Takeaway: In this podcast, Dr. Viral Shah and Dr. Janet McGill discuss the use of RT-CGM in the senior population. Topics discussed include benefits of RT-CGM, addressing barriers and improving utilization in seniors using technology, and clinical study outcomes.

Continuous Glucose Monitoring (CGM): Removing Obstacles and Improving Access for Health Equity Webinar

Presented by:
Daniel DeSalvo, MD
Assistant Professor of Pediatrics in the Section of Diabetes and Endocrinology
Baylor College of Medicine/Texas Children’s Hospital
Houston TX

In diverse and underserved populations research shows there are racial and ethnic disparities in diabetes outcomes. Disparities in diabetes technology use has the greatest influence on glycemic disparities between Black, Hispanic and Non-Hispanic White individuals. A study recently published in Diabetes Care found that lower socio-economic status was associated with lower rates of diabetes technology use and higher levels of A1C. Importantly, this gap in technology has widened over time.  Data published from the T1D exchange, shows that across all age groups, individuals that use continuous glucose monitoring (CGM) have lower A1C levels compared to those who don’t use CGM.

This webinar will highlight the improvements in glycemic and psychosocial outcomes, along with best practices from recent research findings that support the use of CGM in diverse populations. 

The Dexcom G6 Continuous Glucose Monitoring System: Outcomes and Patient Engagement from Real World Data Analytics and Clinical Practice

Source: AMCP Science and Innovation Theater Webinar – November 17, 2020

Key Takeaway: Advances in the Dexcom G6 technology are an important CGM differentiator that allows for improved safety, glycemic management and telehealth opportunities for persons 2 years and older through the use of real-time CGM data with features such as a predictive Urgent Low Soon alert, customizable high/low glycemic threshold alerts, remote monitoring and the CLARITY diabetes management application.

The Clinical and Economic Value of Continuous Glucose Monitoring and Improved Time in Range

Source: AMCP Science and Innovation Theater Webinar

The New Standard of Care: Continuous Glucose Monitoring in Pharmacy Practice

Source: RxInsider


Free On-demand Archive: Continuous Glucose Monitoring: Complete Care Management Solution for Diabetes

Intended Audience: Case Managers – During the CCMC New World Symposium that took place from February 28, 2019, to March 2, 2019, Nicholas B. Argento, MD, FACE, Diabetes Technology Director of Maryland Endocrine in Columbia, Maryland, presented a satellite breakfast symposium on continuous glucose monitoring (CGM) that was sponsored by Dexcom.



Click here to read about this presentation in CareManagement.

Leading CGM Innovation with Dexcom G6® – The Only Fully Interoperable, Zero Fingerstick CGM System – A Science & Innovation Theater held in conjunction with the Academy of Managed Care Pharmacy’s Annual Meeting 2019

Source: AMCP Science and Innovation Theater Webinar

Description: Dexcom G6® is the first CGM to receive the integrated CGM classification by the FDA. Dexcom G6® is approved for use as a standalone CGM and for integration with bluetooth connected insulin pens and automated insulin delivery systems. This presentation will highlight Dexcom’s technology, connected ecosystem, Google/Verily partnership, and future developments including EHR integration, population-level insights, and decision support algorithms.

Continuous Glucose Monitoring and the Opportunities for Optimal Diabetes Care and Cost Management

Free On-demand Webinar:
Continuous Glucose Monitoring and the Opportunities for Optimal Diabetes Care and Cost Management

Intended Audience: This activity is designed for managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.


Osama Eisa, MD
Senior Medical Director
Cigna HealthSpring

Estay Greene, PharmD, MBA
Vice President, Pharmacy Services
Blue Cross Blue Shield of North Carolina

Anita Swamy, MD
Medical Director, Chicago Children’s Diabetes Center
Assistant Professor of Pediatrics, Northwestern Feinberg School of Medicine
La Rabida Children’s Hospital Lurie Children’s

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.

PHP Code Snippets Powered By :